Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 2
2020 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Genotyping performance evaluation of commercially available HIV-1 drug resistance test.
Rosemary A, Chika O, Jonathan O, Godwin I, Georgina O, Azuka O, Zaidat M, Philippe C, Oliver E, Oche A, David O, Jay S, Ibrahim D, Mukhtar A, Joshua D, Chunfu Y, Elliot R, Beth C, Phyllis K, Emmanuel I. Rosemary A, et al. PLoS One. 2018 Jun 28;13(6):e0198246. doi: 10.1371/journal.pone.0198246. eCollection 2018. PLoS One. 2018. PMID: 29953436 Free PMC article.
Distinct Pattern of Thymidine Analogue Mutations with K65R in Patients Failing Tenofovir-Based Antiretroviral Therapy.
Chaplin B, Imade G, Onwuamah C, Odaibo G, Audu R, Okpokwu J, Olaleye D, Meloni S, Rawizza H, Muazu M, Musa AZ, Samuel J, Agbaji O, Ezechi O, Idigbe E, Kanki PJ. Chaplin B, et al. AIDS Res Hum Retroviruses. 2018 Feb;34(2):228-233. doi: 10.1089/AID.2017.0198. Epub 2017 Nov 30. AIDS Res Hum Retroviruses. 2018. PMID: 29084434 Free PMC article.
Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study.
Onwuamah CK, Okpokwu J, Audu R, Imade G, Meloni ST, Okwuraiwe A, Chebu P, Musa AZ, Chaplin B, Dalhatu I, Agbaji O, Samuels J, Ezechi O, Ahmed M, Odaibo G, Olaleye DO, Okonkwo P, Salako BL, Raizes E, Yang C, Kanki PJ, Idigbe EO. Onwuamah CK, et al. BMC Microbiol. 2020 Jan 20;20(1):17. doi: 10.1186/s12866-020-1706-1. BMC Microbiol. 2020. PMID: 31959116 Free PMC article.
Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options.
Meloni ST, Onwuamah CK, Agbaji O, Chaplin B, Olaleye DO, Audu R, Samuels J, Ezechi O, Imade G, Musa AZ, Odaibo G, Okpokwu J, Rawizza H, Mu'azu MA, Dalhatu I, Ahmed M, Okonkwo P, Raizes E, Ujah IAO, Yang C, Idigbe EO, Kanki PJ. Meloni ST, et al. Open Forum Infect Dis. 2017 Nov 2;4(4):ofx233. doi: 10.1093/ofid/ofx233. eCollection 2017 Fall. Open Forum Infect Dis. 2017. PMID: 29255731 Free PMC article.